| Net Cash Provided by (Used in) Operating Activities |
$2,875,187 |
USD |
-208% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$4,511,080 |
USD |
8195% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$960,332 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
700,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
8,954,343 |
shares |
-81% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,585,004 |
USD |
-0.13% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$141,718 |
USD |
10460% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$7,200,179 |
USD |
1144% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$3,131 |
USD |
|
Q1 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$1,757,776 |
USD |
88946% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,442,165 |
USD |
142300% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$59,471,853 |
USD |
100% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
| Depreciation, Depletion and Amortization |
$764 |
USD |
313% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$7,200,674 |
USD |
1144% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |